Delix Therapeutics

company

About

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$70M
Industries
Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale.

The company was founded in 2019 and is headquartered in Boston, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$70M
Delix Therapeutics has raised a total of $70M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2021 Series A $70M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Delix Therapeutics is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series A